Back
Adaptive Biotechnologies Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
ADPT
Adaptive Biotechnologies
Last Price:
$10.49
Seasonality Move:
-8.36%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.
Adaptive Biotechnologies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.44 | Sell |
| 20-day SMA: | 11.37 | Sell |
| 50-day SMA: | 10.28 | Buy |
| 200-day SMA: | 7.59 | Buy |
| 8-day EMA: | 11.2 | Sell |
| 20-day EMA: | 11.17 | Sell |
| 50-day EMA: | 10.37 | Buy |
| 200-day EMA: | 8.05 | Buy |
Adaptive Biotechnologies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 42.76 | Sell |
| Chaikin Money Flow: | -1238304 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.5 - 11.84) | Sell |
| Bollinger Bands (100): | (7.59 - 10.55) | Buy |
Adaptive Biotechnologies Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptive Biotechnologies Stock
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 10.50 while ADPT 8-day simple moving average is 11.44, which is a Sell signal.
-
The stock price of ADPT is 10.50 while Adaptive Biotechnologies 20-day SMA is 11.37, which makes it a Sell.
-
Adaptive Biotechnologies 50-day simple moving average is 10.28 while ADPT share price is 10.50, making it a Buy technically.
-
ADPT stock price is 10.50 and Adaptive Biotechnologies 200-day simple moving average is 7.59, creating a Buy signal.
ADPT Technical Analysis vs Fundamental Analysis
Buy
59
Adaptive Biotechnologies (ADPT)
is a Buy
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a BuyThe current Adaptive Biotechnologies [ADPT] share price is $10.50. The Score for ADPT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Adaptive Biotechnologies Stock Info
Market Cap:
1.6B
Price in USD:
10.50
Share Volume:
1.6M
Adaptive Biotechnologies 52-Week Range
52-Week High:
12.43
52-Week Low:
3.85
Buy
59
Adaptive Biotechnologies (ADPT)
is a Buy
Adaptive Biotechnologies Share Price Forecast
-
What is the Adaptive Biotechnologies stock price today?The Adaptive Biotechnologies stock price is 10.50 USD today.
-
Will ADPT stock go up or go down?Adaptive Biotechnologies> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptive Biotechnologies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptive Biotechnologies is not overvalued.
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 10.50 while ADPT 8-day exponential moving average is 11.20, which is a Sell signal.
-
The stock price of ADPT is 10.50 while Adaptive Biotechnologies 20-day EMA is 11.17, which makes it a Sell.
-
Adaptive Biotechnologies 50-day exponential moving average is 10.37 while ADPT share price is 10.50, making it a Buy technically.
-
ADPT stock price is 10.50 and Adaptive Biotechnologies 200-day simple moving average is 8.05, creating a Buy signal.
Fundamental Analysis of Adaptive Biotechnologies
Is Adaptive Biotechnologies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.27 per share, and an increase next year of $0.24 per share.
Technical Analysis of Adaptive Biotechnologies
Should I short Adaptive Biotechnologies stock?
-
ADPT Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Adaptive Biotechnologies is a Buy
-
Adaptive Biotechnologies Relative Strength Index (RSI) is 42.76, which suggest Adaptive Biotechnologies is oversold
-
The Bollinger Bands (25) for Adaptive Biotechnologies is (10.5 - 11.84), which suggest Adaptive Biotechnologies is a Buy
-
The Bollinger Bands (100) for Adaptive Biotechnologies is (7.59 - 10.55), which suggest Adaptive Biotechnologies is a Buy
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.